These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14819525)

  • 1. The intensity and duration of the effect of depo-heparin on venous coagulation time in man.
    MOSS H; D'ALESSANDRO DR
    Am Pract Dig Treat; 1951 Apr; 2(4):309-10. PubMed ID: 14819525
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-acting heparin preparation: A useful adjunct in anticoagulant therapy. A clinical trial of depo-heparin sodium in 15 cases.
    SMILES WJ
    U S Armed Forces Med J; 1951 Jan; 2(1):45-51. PubMed ID: 14798695
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study.
    Feuring M; Wehling M; Schultz A
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):783-6. PubMed ID: 21883380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays.
    Liestøl S; Wisløff F
    Thromb Res; 2005; 115(6):509-17. PubMed ID: 15792683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
    Ishida M; Nakada Y; Horiuchi M; Sakamoto F
    Arzneimittelforschung; 1998 Aug; 48(8):818-21. PubMed ID: 9748709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viscoelastic pharmacodynamics after dalteparin administration to healthy dogs.
    Brainard BM; Koenig A; Babski DM; Blong AE; Scherk JR
    Am J Vet Res; 2012 Oct; 73(10):1577-82. PubMed ID: 23013183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Express method for determining blood coagulation time].
    Enev N
    Vutr Boles; 1979; 18(2):113-20. PubMed ID: 462931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of dalteparin in reconstructive vascular surgery].
    Pokrovskiĭ AV; Gontarenko VN; Titova MI
    Angiol Sosud Khir; 2011; 17(2):17-22. PubMed ID: 21983457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dalteparin: pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseases.
    Pineo GF; Hull RD
    Eur J Med Res; 2004 Apr; 9(4):215-24. PubMed ID: 15210402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments.
    WESSLER S
    J Clin Invest; 1953 Jul; 32(7):650-4. PubMed ID: 13069611
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring of low molecular weight heparin anticoagulation during haemodialysis with a Sonoclot Analyzer.
    Schött U; Nilsson LG; Broman M; Engström M
    Perfusion; 2010 Jul; 25(4):191-6. PubMed ID: 20530518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J; Johnston N; Siegbahn A
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease.
    Oldgren J; Fellenius C; Boman K; Jansson JH; Nilsson TK; Wallentin L; Siegbahn A
    J Intern Med; 2005 Nov; 258(5):420-7. PubMed ID: 16238677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low molecular weight heparin on clot rate and activated clotting time: an in vitro study.
    Shi XB; Bai Y; Li J; Xiao J; Wang JQ; Zheng H
    Chin Med J (Engl); 2013; 126(18):3553-6. PubMed ID: 24034107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of caronamide and heparin on the coagulation time of human blood.
    SIRAK HD; McCLEERY RS; ARTZ CP
    Health Cent J; 1948 Mar; 1(2):112. PubMed ID: 18934526
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of depo-heparin on the prothrombin time, with observations on the combined use of heparin and dicumarol.
    HOLYOKE JB; WHEELWRIGHT HJ
    N Engl J Med; 1952 Jan; 246(1):15-7. PubMed ID: 14882481
    [No Abstract]   [Full Text] [Related]  

  • 20. [EFFECT OF SURGERY ON BLOOD COAGULATION].
    ZYKAS V
    Sveikatos Apsauga; 1963 Dec; 8():8-13. PubMed ID: 14111268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.